Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05592626
Title	A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors (START-001)
Acronym	START-001
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Marengo Therapeutics, Inc.
Indications	triple-receptor negative breast cancer lung non-small cell carcinoma colorectal cancer castration-resistant prostate carcinoma ovary epithelial cancer prostate cancer Advanced Solid Tumor
Therapies	STAR0602
Age Groups:	adult \| senior
Covered Countries	USA \| CAN